Roche buys US biotech Jecure in race for liver disease drugs

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 66%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

Swiss drugmaker Roche is buying U.S.-based Jecure Therapeutics, joining Pfizer, Gilead Sciences and Novartis in pursuit of new drugs to treat ...

Source: Healthcare Press (healthcarepress.net)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Roche sues US executives in fight over diabetes test stripsRoche is seeking tens of millions of dollars in damages and compensation in a U.S. lawsuit against former executives of a Utah-based company, the ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Roche to buy gene therapy specialist Spark in US$4.3 billion dealRoche on Monday said it will buy Spark Therapeutics in a transaction valued at US$4.3 billion as the Swiss drugmaker builds its hemophilia ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Roche extends Spark offer after getting only 29 percentZURICH: Roche Holding has extended until May 2 its US$4.3 billion offer for U.S. gene therapy specialist Spark Therapeutics, the Swiss drugmaker ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Roche's lung cancer combo treatment wins FDA approvalSwiss drugmaker Roche Holding AG said on Thursday that its Tecentriq immunotherapy in combination with chemotherapy was approved by the U.S. Food ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Gilead Sciences to hire Roche executive O'Day as new CEO: sourceDrugmaker Gilead Sciences Inc will name Roche Holding AG executive Daniel O'Day as its new chief executive officer, according to a source familiar ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Gilead Sciences hires Roche executive Daniel O'Day as CEODrugmaker Gilead Sciences Inc will name Roche Holding AG executive Daniel O'Day as its new chief executive officer, according to a source familiar ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Gilead Sciences snares Roche veteran O'Day as CEODrugmaker Gilead Sciences Inc will name Roche Holding AG executive Daniel O'Day as its new chief executive officer, according to a source familiar ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Novartis goes after Roche asthma medicine Xolair with new drugNovartis said it is pushing ahead with a late-stage study of its experimental drug ligelizumab after announcing the medicine outperformed Roche's ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Roche says Hemlibra effective in pivotal studyRoche's Hemlibra provided sustained bleed control in the largest pivotal study to date of children with a form of haemophilia, the Swiss drugmaker ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Roche to make Hemlibra donation to boost accessSwiss drugmaker Roche plans to donate its new hemophilia A drug Hemlibra to a program run by the World Hemophilia Federation, hoping to provide ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »